Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHYR.L Regulatory News (HYR)

  • There is currently no data for HYR

Acquisition

25 Jun 2008 07:00

RNS Number : 4554X
HydroDec Group plc
25 June 2008
 



 

Not for release, publication or distribution, in whole or in part in, into or from the United States of America or any of its territories, Canada, or Japan, or any other jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction.

 

 

 

25th June 2008

 

 

 

RECOMMENDED ACQUISITION

by

Hydrodec Group plc ("Hydrodec")

of

Virotec International plc ("Virotec")

Scheme of Arrangement becomes Effective

 

The scheme of arrangement under sections 895 to 901 of the Companies Act 2006 (the "Scheme") and the claim form to confirm the Reduction under section 137 of the 2006 Act to implement the recommended acquisition by Hydrodec of the entire issued and to be issued share capital of Virotec (other than the Excluded Shares) has now become effective in accordance with the terms of the Scheme and the Acquisition has been completed. 

Under the terms of the Scheme, Virotec Shareholders are entitled to receive 1 New Hydrodec Share for every 3.75 Scheme Shares held in Virotec. 

Dealings in Virotec Shares on AIM have been cancelled at Hydrodec's request, with effect from 7.00am today. 

Settlement of the Cash Consideration in respect of the Virotec Shares will be effected within 14 days of today in accordance with the terms of the Scheme. Application has been made for the admission to trading on AIM of 64,689,227 New Hydrodec Shares. These New Hydrodec Shares, which will rank pari passu in all respects with the existing shares in issue, have been allottedAdmission and Commencement of dealings in the New Hydrodec Shares on AIM is expected to become effective on 25 June 2008.

 

For the purposes of the Financial Services Authority's Disclosure and Transparency Rules, the total number of ordinary shares of 0.5p each of Hydrodec in issue on the date of admission will be 268,718,839 with each share holding one voting right. 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure and Transparency Rules.

Capitalised terms used but not defined in this announcement have the same meanings as set out in the scheme document dated 13 May 2008. 

Enquires:

John Gunn 

Hydrodec Group plc 

+44 (0) 20 7621 5770 

Anthony Richardson 

Nick Westlake 

Numis Securities Limited 

+44 (0) 20 7260 1000 

Emma Davis

Curve Public Relations

+44 (0) 20 8742 1597

Numis Securities Limited, which is regulated in the United Kingdom by the Financial Services Authority, is acting for Hydrodec and no-one else in connection with the Acquisition and will not be responsible to anyone other than Hydrodec for providing the protections afforded to customers of Numis Securities Limited or for providing advice in relation to the Acquisition or any other matter referred to herein. 

 

 

Ludgate Investments Limited, which is regulated in the United Kingdom by the Financial Services Authority, is acting for Hydrodec and no-one else in connection with the Acquisition and will not be responsible to anyone other than Hydrodec for providing the protections afforded to customers of Ludgate Investments Limited or for providing advice in relation to the Acquisition or any other matter referred to herein. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQEAXKLAALPEFE
Date   Source Headline
7th Apr 20117:00 amRNSFinal Results
8th Mar 201111:22 amRNSNotice of Results
24th Jan 20117:00 amRNSNotification of Interest
17th Jan 20111:03 pmRNSDirector's dealing in securities
5th Jan 20113:17 pmRNSNotification of Interest
2nd Dec 20107:00 amRNSTrading Update
9th Nov 201012:19 pmRNSNotification of Interest
1st Nov 201010:59 amRNSNotification of Interest
29th Oct 20104:12 pmRNSTotal Voting Rights
25th Oct 201010:56 amRNSLoan Note Conversion Price Adjustment
25th Oct 201010:56 amRNSLoan Note Conversion Price Adjustment
21st Oct 201011:43 amRNSNotification of Interest
21st Oct 201011:43 amRNSNotification of Interest
19th Oct 20104:41 pmRNSNotification of Interest
14th Oct 201010:36 amRNSResult of General Meeting
8th Oct 20105:13 pmRNSNotification of Interest
4th Oct 20104:16 pmRNSNotification of Interest
24th Sep 20104:27 pmRNSPosting of Circular
24th Sep 201011:35 amRNSPlacement of Ordinary Shares
31st Aug 20107:00 amRNSUnaudited Interim Results
25th Aug 201010:00 amRNSNotice of Results
19th Jul 20107:00 amRNSTrading Update
9th Jul 20104:27 pmRNSNotification of Interest
9th Jul 201010:18 amRNSNotification of Interest
5th Jul 20101:33 pmRNSNotification of Interest
2nd Jul 201011:24 amRNSDirector's Dealing
8th Jun 20109:34 amRNSLoan Note Conversion Price Adjustment
27th May 201011:42 amRNSResult of AGM
27th May 20107:00 amRNSAGM Statement and Trading Update
6th May 20101:14 pmRNSNotification of Interest
5th May 201011:14 amRNSAnnual Report and Notice of AGM
4th May 201010:06 amRNSTotal Voting Rights
29th Apr 20102:45 pmRNSNOTIFICATION OF INTEREST IN SHARES
28th Apr 20107:00 amRNSFinal Results
22nd Apr 20102:45 pmRNSNotice of Results
13th Apr 201010:35 amRNSResult of General Meeting
31st Mar 20105:35 pmRNSNotification of Interest
31st Mar 201011:06 amRNSTotal Voting Rights
26th Mar 20104:00 pmRNSPosting of Circular
23rd Mar 20107:00 amRNSPlacement of Ordinary Shares
19th Mar 20107:00 amRNSPotential fund raising and strategic investment
4th Mar 20107:00 amRNSJapanese Strategic Alliance Agreement
1st Feb 201012:18 pmRNSTotal Voting Rights
15th Jan 20109:14 amRNSTrading Update
13th Jan 201010:29 amRNSJapanese Approval of Technology
12th Jan 20102:50 pmRNSDirector's Dealing in Securtiities
7th Jan 201011:44 amRNSResult of Meeting
31st Dec 20097:00 amRNSTotal Voting Rights
23rd Dec 20091:39 pmRNSNotification of Major Interest in Shares
16th Dec 20097:00 amRNSPosting of circular

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.